Definium Therapeutics, Inc. DFTX
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-05-04
Definium Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 1,489,242 | $28.1M | 1.51% |
| TWO SIGMA INVESTMENTS, LP | 1,201,610 | $22.7M | 1.22% |
| MILLENNIUM MANAGEMENT LLC | 846,896 | $16.0M | 0.86% |
| D. E. Shaw & Co., Inc. | 271,717 | $5.1M | 0.28% |
| Point72 Asset Management, L.P. | 175,490 | $3.3M | 0.18% |
| AQR CAPITAL MANAGEMENT LLC | 57,094 | $1.1M | 0.06% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.